Tahoe Hospital Management Co. Ltd. and UPMC reached a five-year agreement under which UPMC will assist in the planning and operation of an expanded cancer center within an existing private hospital in Beijing.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
